Clinical Nutrition Market to grow at 7% CAGR from 2017 to 2024 (1) - PowerPoint PPT Presentation

About This Presentation

Clinical Nutrition Market to grow at 7% CAGR from 2017 to 2024 (1)


Get more details @ Few players dominate clinical nutrition market such as Abbott Laboratories, Nestle, Danone, Fresenius Kabi, Hospira, Perrigo, B Braun Melsungen, Baxter International and Mead Johnson. – PowerPoint PPT presentation

Number of Views:74


Transcript and Presenter's Notes

Title: Clinical Nutrition Market to grow at 7% CAGR from 2017 to 2024 (1)

Global Clinical Nutrition Market forecast to grow
at 7 CAGR from 2017 to 2024
Key Insights of Clinical Nutrition Market
  • The world has been witnessing a continuous rise
    in the number of metabolic disorders and
    pre-mature deaths due to malnutrition.
  • Clinical nutrition market expansion can be
    primarily credited to the aforementioned factors,
    as per research analysis.
  • Rising health consciousness and an escalating
    preference for home healthcare has led to swift
    improvements in clinical nutrition design
    composition, which will ultimately push clinical
    nutrition market size.
  • The pharmaceutical and food beverage sectors
    are the major end-use domains that will
    experience a widespread usage of this product.
  • Considering the geographical trends, Asia Pacific
    industry, which contributed over 40 of clinical
    nutrition market share in 2015, is set to hit a
    targeted revenue of over USD 30 billion by 2024.
  • Latin America clinical nutrition industry is
    projected to surpass a revenue of USD 6 billion
    by 2024, registering a CAGR of more than 8 over

  • Mounting incidences of malnourishment coupled
    with improvement in healthcare services are
    predicted to contribute towards the industry
    revenue. Mexico and Brazil are slated to be key
    growth drivers of the region.
  • Germany and UK, both of which contributed to over
    18 and 17 of Europe clinical nutrition industry
    revenue respectively in 2015, are also expected
    to make notable contributions toward the industry
    development in the future.
  • U.S. clinical nutrition industry market, which
    was evaluated at USD 8 billion in 2015, is
    projected to record significant gains of over 6
    during 2017 to 2024.
  • Enteral nutrition, infant nutrition, and
    parenteral nutrition are some of the major
    products of clinical nutrition market.
  • Parenteral clinical nutrition market, worth USD
    4.2 billion in 2015, is anticipated to hit USD 7
    billion by 2024.
  • Abbott Laboratories, B Braun Melsungen AG,
    Hospira, Danone, Fresenius Kabi, Nestle S.A., and
    The H. J. Heinz Company are the key participants
    of clinical nutrition market.

Europe Clinical Nutrition Market, By Product,
2012 - 2024 (USD Million)


Browse Full Market Research Report of Clinical
Nutrition Market _at_ http//
Request for a Sample of this Research report
_at_ https//

Table of Contents
Chapter 1. Methodology Scope 1.1 Research
Methodology 1.1.1 Initial
data exploration 1.1.2 Statistical model
and forecast 1.1.3 Industry insights and
validation 1.1.4 Market definition and
forecast parameters 1.2 Data Sources
1.2.1 Primary 1.2.2 Secondary
Chapter 2. Executive Summary 2.1
Clinical Nutrition industry 3600 synopsis, 2012 -
2024 2.1.1 Business trends
2.1.2 Product trends 2.1.3 Regional
Chapter 3. Clinical Nutrition Industry
Insights 3.1 Industry segmentation
3.2 Industry size forecast, 2012 -
2024 3.3 Industry ecosystem analysis 3.3.1
Distribution channel analysis 3.4
Industry impact forces
3.4.1 Growth Drivers
Increasing metabolic disorders and other chronic
diseases Junk food habits leading to
malnourishment in U.S. Europe
Increasing geriatric population
Increasing rate of pre-mature birth birth rate
in APAC Increasing adoption of home
healthcare in North America and Europe 3.4.2
Industry pitfalls Challenges
Stringent government regulations in U.S., Europe,
and APAC Lack of awareness regarding
nutrition in developing countries 3.5 Growth
potential analysis
3.6 Regulatory landscape
3.6.1 U.S. 3.6.2 Europe 3.6.3
China 3.7 Reimbursement scenario 3.7.1
U.S. 3.7.2 Europe 3.8 Pipeline analysis 3.9
Pricing analysis 3.9.1 North America 3.9.2
Europe 3.9.3 Asia Pacific 3.9.4 Latin
America 3.9.5 MEA 3.10 Volume analysis 3.10.1
North America 3.10.2 Europe 3.10.3
Asia-Pacific 3.10.4 Latin-America 3.10.5 Middle
East Africa
3.11 Patent Landscape 3.11.1 Infant
nutrition 3.11.2 Enteral Nutrition 3.11.3
Parenteral nutrition 3.12 Porter's Analysis
3.13 PESTEL Analysis 3.14 Company
market share analysis, 2016 3.14.1.
Revenue 3.14.2. Product landscape 3.14.2.
Strategic landscape
Stay In Touch Website https//
Social Media
Write a Comment
User Comments (0)